sk&f 107260 has been researched along with sb 223245 in 2 studies
Studies (sk&f 107260) | Trials (sk&f 107260) | Recent Studies (post-2010) (sk&f 107260) | Studies (sb 223245) | Trials (sb 223245) | Recent Studies (post-2010) (sb 223245) |
---|---|---|---|---|---|
11 | 0 | 0 | 7 | 0 | 0 |
Protein | Taxonomy | sk&f 107260 (IC50) | sb 223245 (IC50) |
---|---|---|---|
Integrin beta-3 | Homo sapiens (human) | 0.145 | |
Integrin alpha-V | Homo sapiens (human) | 0.145 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, FE; Callahan, JF; Calvo, RR; Huffman, WF; Hwang, SM; Keenan, RM; Kopple, KD; Kwon, C; Miller, WH; Peishoff, CE; Samanen, JM; Wong, AS; Yuan, CK | 1 |
Gottschalk, KE; Kessler, H; Lavecchia, A; Marinelli, L; Novellino, E | 1 |
2 other study(ies) available for sk&f 107260 and sb 223245
Article | Year |
---|---|
Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists.
Topics: Binding Sites; Oligopeptides; Protein Conformation; Receptors, Vitronectin | 1997 |
Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.
Topics: Algorithms; Benzodiazepines; Crystallization; Crystallography, X-Ray; Drug Design; Hydrogen Bonding; Integrin alphaVbeta3; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Mutagenesis, Site-Directed; Oligopeptides; Protein Conformation; Stereoisomerism; Structure-Activity Relationship | 2003 |